Who owns LIPELLA PHARMACEUTICALS INC?
- Ticker: LIPO
- CUSIP Number: 53630l100
Tip: Access positions for across all investors
Analyze quarterly positions in Lipella Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lipella Pharmaceuticals stock
Who bought or sold LIPELLA PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 42k | $29k | 100% | Mar 2024 |
|
| Vanguard Group | 35k | $24k | 0% | Mar 2024 |
|
| Citadel Advisors | 22k | $15k | 100% | Mar 2024 |
|
| Two Sigma Investments | 13k | $9.0k | -18% | Mar 2024 |
|
| Hrt Financial | 10k | $7.0k | 100% | Mar 2024 |
|
| Tower Research Capital | 7.7k | $5.3k | 57% | Mar 2024 |
|
| FMR | 65.00 | $44.999500 | 100% | Mar 2024 |
|
| Wells Fargo & Company | 30.00 | $21.000000 | 3% | Mar 2024 |
|
Who sold out of Lipella Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Dec 2023 | 761.00 | $775.991700 |